Remedy for 340B-Acquired Drug Payment Policy Proposed Rule Summary
FMA presents a detailed summary of the proposed rule describing the Agency’s proposed actions to craft a remedy relating to the adjustment of Medicare payment rates for drugs acquired under the 340B Program from calendar 2018 through September 27, 2022.
Medicaid Drug Misclassification Proposed Rule Summary
The rule proposes to implement policies in the Medicaid Drug Rebate Program (MDRP) related to legislative requirements addressing drug misclassification, as well as drug pricing and product data misreporting by manufacturers.
Ensuring Access to Medicaid Services Proposed Rule Summary
On May 3, 2023, CMS published in the Federal Register a proposed rule entitled “Medicaid Program; Ensuring Access to Medicaid Services” (88 FR 27960-28089). The rule proposes policies that take a comprehensive approach to improving access to care, quality and health outcomes, and better addressing health equity issues in the Medicaid program across fee-for-service, managed care delivery…
FY 2024 IPPS/LTCH Proposed Rule Summary
HFMA presents a detailed summary of its proposed rule describing federal fiscal year (FY) 2024 policies and rates for Medicare’s inpatient prospective payment system and the long-term care hospital prospective payment system.
FY 2024 Skilled Nursing Facilities PPS Proposed Rule Summary
HFMA presents a detailed summary of the proposed rule updating the Medicare skilled nursing facility (SNF) payment rates for fiscal year (FY) 2024.
FY 2024 Inpatient Psychiatric Facilities Prospective Payment System Proposed Rule Summary
HFMA presents a detailed summary of the fiscal year (FY) 2024 Inpatient Psychiatric Facilities Prospective Payment System proposed rule, published in the April 10, 2023, Federal Register.
FY 2024 Hospice Wage Index and Payment Rate Update Proposed Rule Summary
HFMA presents a detailed summary of the proposed rule updating the Medicare hospice payment rates, wage index, the cap amount, and the quality reporting requirements for federal fiscal year (FY) 2024.
Medicare Drug Price Negotiation Program Guidance
HFMA presents a summary of CMS proposed initial guidance memorandum pertaining to the Medicare Drug Price Negotiation Program.
Highlights of the Administration’s FY 2024 Budget
HFMA presents a summary of healthcare-related proposals included in the President’s budget for fiscal year 2024, released by the Biden Administration on March 9, 2023.
Medicaid DSH Third-Party Payer Proposed Rule Summary
HFMA presents a detailed summary of the proposed rule that would address legislative changes to the hospital-specific limit on Medicaid DSH payments as a result of the Consolidated Appropriations Act, 2021.